AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 44 filers reported holding AXOVANT GENE THERAPIES LTD in Q2 2020. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $246,000 | +58.7% | 53,225 | -3.4% | 0.00% | – |
| Q2 2020 | $155,000 | -13.9% | 55,125 | -25.3% | 0.00% | – |
| Q1 2020 | $180,000 | -70.8% | 73,825 | -38.7% | 0.00% | – |
| Q4 2019 | $617,000 | -22.5% | 120,425 | -2.3% | 0.00% | -100.0% |
| Q3 2019 | $796,000 | +2.8% | 123,287 | -0.8% | 0.00% | 0.0% |
| Q2 2019 | $774,000 | – | 124,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|